Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
200 employees · est. 2008 · Abingdon, United Kingdom
Olema Oncology is the older company (2008 vs 2007).
Side-by-Side Comparison
| Metric | Adaptimmune | Olema Oncology |
|---|---|---|
| Founded | ||
| Founded | 2008 | 2007 older |
| Headquarters | ||
| Headquarters | Abingdon, United Kingdom | San Francisco, United States |
| Employees | ||
| Employees | 200 | 164 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $499.50M | $325.05M |
| Funding Rounds | ||
| Funding Rounds | 9 | 5 |
| Services | ||
| Services | Development of T-cell therapies, Pipeline management of cell therapies, Sale and licensing of cell therapies, Biotechnological research, Clinical trials | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare professionals, Biopharmaceutical companies, Medical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Cancer Treatment, T Cell Therapies, Preclinical Research, Clinical Development, Translational Sciences, Autologous Manufacturing, Allogeneic Manufacturing, T Cell Receptor Proteins, Affinity T Cell Receptor, Immunotherapy, Infectious Disease Treatment, HIV Therapy, Corporate Operations | Biopharmaceutical Company, Targeted Therapies, Women's Cancers, OP-1250, Estrogen Receptor Antagonist, Breast Cancer Treatment, Phase 1/2 Clinical Trial, Healthcare Investors, Pharmaceutical Development, Innovative Therapies, Clinical Research, Oncology, Biotech, Scientific Research |
| Website | ||
| Website | adaptimmune.com | olema.com |
About Adaptimmune
Adaptimmune stands as a pioneering entity in the biopharmaceutical landscape, specializing in cell therapies designed to revolutionize cancer treatment. With its strong presence in four biotechnology hubs across the U.K. and U.S., the company showcases comprehensive competencies ranging from preclin...
About Olema Oncology
Olema Oncology is a biopharmaceutical company that focuses on developing innovative targeted therapies for women's cancers. Their lead program, OP-1250, is a potential best-in-class complete estrogen receptor antagonist (CERAN) designed to treat estrogen receptor-positive (ER+), human epidermal grow...
We will tell you when either one moves
BounceWatch watches Adaptimmune and Olema Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Adaptimmune and Olema Oncology — by email.
Frequently Asked Questions
Compare Adaptimmune with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Adaptimmune on 11 Mar 2026, and Olema Oncology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.